Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 63

1.

Implications of epigenetic mechanisms for vascular development and disease.

Hagemann S, Brönneke S, Winnefeld M.

Epigenomics. 2012 Oct;4(5):475-7. doi: 10.2217/epi.12.43. No abstract available.

PMID:
23130827
2.

Epigenetic changes in cancer.

Iacobuzio-Donahue CA.

Annu Rev Pathol. 2009;4:229-49. doi: 10.1146/annurev.pathol.3.121806.151442. Review.

PMID:
18840073
3.

Epigenetic regulation of cancer stem cell gene expression.

Bapat SA.

Subcell Biochem. 2013;61:419-34. doi: 10.1007/978-94-007-4525-4_18. Review.

PMID:
23150261
4.

Sixteenth Annual Pezcoller Symposium: stem cells and epigenesis in cancer.

Mihich E, Jaenisch R.

Cancer Res. 2004 Nov 15;64(22):8474-7.

5.

DNA methylation and cancer.

Gokul G, Khosla S.

Subcell Biochem. 2013;61:597-625. doi: 10.1007/978-94-007-4525-4_26. Review.

PMID:
23150269
6.

[Nuclear atypia and epigenetic change].

Ichimura T, Ito T.

Tanpakushitsu Kakusan Koso. 2006 Nov;51(14 Suppl):2049-51. Review. Japanese. No abstract available.

PMID:
17471907
7.

Epigenetics: surveillance team against cancer.

Klein G.

Nature. 2005 Mar 10;434(7030):150. No abstract available.

PMID:
15758980
8.

Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.

Sigalotti L, Fratta E, Coral S, Cortini E, Covre A, Nicolay HJ, Anzalone L, Pezzani L, Di Giacomo AM, Fonsatti E, Colizzi F, Altomonte M, Calabrò L, Maio M.

J Cell Physiol. 2007 Aug;212(2):330-44. Review.

PMID:
17458893
9.

The role of epigenetic transcription repression and DNA methyltransferases in cancer.

Daniel FI, Cherubini K, Yurgel LS, de Figueiredo MA, Salum FG.

Cancer. 2011 Feb 15;117(4):677-87. doi: 10.1002/cncr.25482. Epub 2010 Oct 13. Review.

10.

[Molecular mechanisms involved in epigenetic alterations in cancer].

Toyota M, Suzuki H, Nishizaka T, Sato A, Yamashita T.

Gan To Kagaku Ryoho. 2010 Sep;37(9):1650-3. Japanese.

PMID:
20841926
11.

Excavating relics of DNA methylation changes during the development of neoplasia.

Hsiao SH, Huang TH, Leu YW.

Semin Cancer Biol. 2009 Jun;19(3):198-208. doi: 10.1016/j.semcancer.2009.02.015. Epub 2009 Mar 5. Review.

PMID:
19429484
12.

Epigenetic and chromatin modifiers as targeted therapy of hematologic malignancies.

Bhalla KN.

J Clin Oncol. 2005 Jun 10;23(17):3971-93. Epub 2005 May 16. Review.

PMID:
15897549
13.

[Epigenetic processes in malignant transformation: the role of DNA methylation in cancer development].

Suijkerbuijk KP, van der Wall E, van Laar T, Vooijs M, van Diest PJ.

Ned Tijdschr Geneeskd. 2007 Apr 21;151(16):907-13. Review. Dutch.

PMID:
17500342
14.

[Targeting epigenetics plasticity as a novel target for human neoplasia].

Shinjo K, Kondo Y.

Gan To Kagaku Ryoho. 2010 Sep;37(9):1654-8. Japanese.

PMID:
20841927
15.

How does DNA methylation mark the fate of cells?

Macaluso M, Giordano A.

Tumori. 2004 Jul-Aug;90(4):367-72. Review.

PMID:
15510977
16.

Epigenetics and cancer.

Verma M, Maruvada P, Srivastava S.

Crit Rev Clin Lab Sci. 2004;41(5-6):585-607. Review.

PMID:
15603512
17.

Epigenetic control of smooth muscle cell differentiation and phenotypic switching in vascular development and disease.

Alexander MR, Owens GK.

Annu Rev Physiol. 2012;74:13-40. doi: 10.1146/annurev-physiol-012110-142315. Epub 2011 Oct 10. Review.

PMID:
22017177
18.

[Master and servant: epigenetic deregulations as a cause and a consequence of cancer].

Laget S, Defossez PA.

Med Sci (Paris). 2008 Aug-Sep;24(8-9):725-30. doi: 10.1051/medsci/20082489725. Review. French.

19.

Cancer: an epigenetic landscape.

Dhanasekaran K, Arif M, Kundu TK.

Subcell Biochem. 2013;61:399-417. doi: 10.1007/978-94-007-4525-4_17. Review. No abstract available.

PMID:
23150260
20.

The cancer epigenome--components and functional correlates.

Ting AH, McGarvey KM, Baylin SB.

Genes Dev. 2006 Dec 1;20(23):3215-31. Review.

Supplemental Content

Support Center